Related Experiment Video

Updated: Apr 16, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

6.1K

Survivin small interfering RNA suppresses glioblastoma growth by inducing cellular apoptosis

Yanbo Liu1, Chunming Miao1, Zhenjiang Wang1

  • 1Beihua University Faculty of Medicine, Jilin 132013, Jilin Province, China.

Neural Regeneration Research
|February 28, 2015
PubMed

Insights

Small interfering RNA targeting survivin effectively inhibited glioma cell growth and promoted apoptosis in vitro and in vivo. This suggests RNA interference targeting survivin may be a promising glioma treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioblastoma is an aggressive brain tumor with limited treatment options.
  • Survivin is a protein that promotes cancer cell survival and proliferation.
  • Targeting survivin offers a potential therapeutic strategy for glioblastoma.

Purpose of the Study:

  • To investigate the efficacy of survivin small interfering RNA (siRNA) in inhibiting glioma growth.
  • To evaluate the potential of RNA interference (RNAi) as a treatment for glioma.

Main Methods:

  • Constructed a survivin-specific small interfering RNA (siRNA) targeting a conserved human and mouse sequence.
  • Transfected siRNA into human U251 and rat C6 glioma cell lines in vitro.
  • Administered siRNA to rat orthotopic glioma models in vivo.

Main Results:

  • Survivin siRNA significantly inhibited glioma cell proliferation in both human and rat cell lines.
  • Survivin siRNA induced apoptosis in glioma cells in vitro.
  • Treatment with survivin siRNA demonstrated inhibition of glioma tumor growth in vivo.

Conclusions:

  • Survivin siRNA effectively suppresses glioma cell proliferation and induces apoptosis.
  • RNA interference targeting survivin shows potential as a therapeutic approach for glioma treatment.
  • Further research into survivin-targeted RNAi is warranted for clinical application in glioma therapy.
Keywords:
RNA interferenceapoptosisglioblastomasurvivin

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K
A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

13.2K

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.1K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

5.4K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.9K
RNA Interference01:23

RNA Interference

7.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K